In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy ...

British pharmaceuticals giant AstraZeneca has revealed it plans to invest $50 billion (£37 billion) in America over the next ...

AstraZeneca (AZN) said it is investing $50 billion in US manufacturing by 2030, following the lead of big pharma peers that ...

In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a ...

AstraZeneca has announced a US$50 billion investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D.This investment is expected to create tens ...

Americans have been clamoring for sensible prescription drug reform for years. With the stroke of his pen, President Donald Trump answered that call. His executive order aims to bring down drug prices ...

AstraZeneca announces $50B US investment by 2030, creating thousands of jobs and building its largest drug manufacturing facility in Virginia.

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...

Virginia facility investment will be AstraZeneca’s largest yet. Maryland, Massachusetts, California, Indiana, Texas projects ...

Global nanoemulsion industry was estimated at $2.08 billion in 2018 and is expected to reach $4.91 billion by 2026, growing at a CAGR of 11.5% from 2 ...

AstraZeneca today announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create ...

Millions of people suffer debilitating reactions in the presence of certain scents and chemicals. One scientist has been ...